A Systematic Approach to Differentiating Joint Disorders A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Rheuma.Stamp Line&Box
Arthritis Mutilans: A Report from the GRAPPA 2012 Annual Meeting Vinod Chandran, Dafna D. Gladman, Philip S. Helliwell, and Björn Gudbjörnsson ABSTRACT. Arthritis mutilans is often described as the most severe form of psoriatic arthritis. However, a widely agreed on definition of the disease has not been developed. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members hoped to agree on a definition of arthritis mutilans and thus facilitate clinical and molecular epidemiological research into the disease. Members discussed the clinical features of arthritis mutilans and defini- tions used by researchers to date; reviewed data from the ClASsification for Psoriatic ARthritis study, the Nordic psoriatic arthritis mutilans study, and the results of a premeeting survey; and participated in breakout group discussions. Through this exercise, GRAPPA members developed a broad consensus on the features of arthritis mutilans, which will help us develop a GRAPPA-endorsed definition of arthritis mutilans. (J Rheumatol 2013;40:1419–22; doi:10.3899/ jrheum.130453) Key Indexing Terms: OSTEOLYSIS ANKYLOSIS PENCIL-IN-CUP SUBLUXATION FLAIL JOINT ARTHRITIS MUTILANS Psoriatic arthritis (PsA) is an inflammatory musculoskeletal gists as a severe destructive form of PsA, a precise disease specifically associated with psoriasis. Moll and definition has not yet been universally accepted. The earliest Wright defined PsA as “psoriasis associated with inflam- definition of arthritis mutilans was provided -
Psoriatic Arthritis Howard Duncan
Henry Ford Hospital Medical Journal Volume 13 | Number 2 Article 6 6-1965 Psoriatic Arthritis Howard Duncan Darrell Oberg William R. Eyler Follow this and additional works at: https://scholarlycommons.henryford.com/hfhmedjournal Part of the Life Sciences Commons, Medical Specialties Commons, and the Public Health Commons Recommended Citation Duncan, Howard; Oberg, Darrell; and Eyler, William R. (1965) "Psoriatic Arthritis," Henry Ford Hospital Medical Bulletin : Vol. 13 : No. 2 , 173-181. Available at: https://scholarlycommons.henryford.com/hfhmedjournal/vol13/iss2/6 This Article is brought to you for free and open access by Henry Ford Health System Scholarly Commons. It has been accepted for inclusion in Henry Ford Hospital Medical Journal by an authorized editor of Henry Ford Health System Scholarly Commons. For more information, please contact [email protected]. Henry Ford Hosp. Med. Bull. Vol. 13, June, 1965 PSORIATIC ARTHRITIS* HOWARD DUNCAN, M.D.,** DARRELL OBERG, M.D.,** AND WILLIAM R. EYLER, M.D.*** Dr. Howard Duncan. It is apparent from these meetings that rheumatologists are not alone in having troubles with dissension amongst the hierarchy in arriving at a decision as to whether a disease exists or not. The problem is the relationship between arthritis and psoriasis. Our first approach will be to demonstrate that there is an entity "psoriatic arthritis" which is distinct from rheumatoid arthritis with psoriasis. I'll ask Dr. Oberg to illustrate the situation. Dr. Darrell Oberg. Our patient is a 49 year old white female who was first .seen in this hospital in 1960, at which time she was admitted with malignant hypertension, which has subsequently been controlled by treatment prescribed in the Hypertension Division. -
Spondyloarthropathies and Reactive Arthritis
RHEUMATOLOGY SPONDYLOARTHRITIS ROBERT L. DIGIOVANNI, DO, FACOI PROGRAM DIRECTOR LMC RHEUMATOLOGY FELLOWSHIP [email protected] DISCLOSURES •NONE SERONEGATIVE SPONDYLOARTHROPATHIES SLIDES PREPARED BY GENE JALBERT, DO SENIOR RHEUMATOLOGY FELLOW THE SPONDYLOARTHROPATHIES: • Ankylosing Spondylitis (A.S.) • Non-radiographic Axial spondyloarthropathies (nr-axSpA) • Psoriatic Arthritis (PsA) • Inflammatory Bowel Disease Associated (Enteropathic) • Crohn and Ulcerative Colitis • +/- Microscopic colitis • Reactive Arthritis (ReA) • Juvenile-Onset SpA • Others: Bechet’s dz, Celiac, Whipples, pouchitis. THE FAMOUS VENN DIAGRAM: SPONDYLOARTHROPATHY: • First case of Axial SpA was reported in 1691 however some believe Ramses II has A.S. • 2.4 million adults in the United States have Seronegative SpA • Compare with RA, which affects about 1.3 million Americans • Prevalence variation for A.S.: Europe (0.12-1%), Asia (0.17%), Latin America (0.1%), Africa (0.07%), USA (0.34%). • Pathophysiology in general: • Responsible Interleukins: IL-12, IL17, IL-22, and IL23. SPONDYLOARTHROPATHY: • Axial SpA: • Radiographic (Sacroiliitis seen on X- ray) • No Radiographic features non- radiographic SpA (nr-SpA) • Nr-SpA was formally known as undifferentiated SpA • Peripheral SpA: • Enthesitis, dactylitis and arthritis • Eventually evolves into a specific diagnosis A.S., PsA, etc. • Can be a/w IBD, HLA-B27 positivity, uveitis SHARED CLINICAL FEATURES: • Axial joint disease (especially SI joints) • Asymmetrical Oligoarthritis (2-4 joints). • Dactylitis (Sausage -
Effects of Tofacitinib in Early Arthritis-Induced Bone Loss in an Adjuvant-Induced Arthritis Rat Model
Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model Vidal B.1, Cascão R.1, Finnilä MA.2,3, IP. Lopes1, da Glória VG.1, Saarakkala S.2,4, Zioupos P.5, Canhão H.6, Fonseca JE.1,7 1 Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; 2 Research Unit of Medical Imaging, Physics and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland; 3 Department of Applied Physics, University of Eastern Finland, Kuopio, Finland; 4 Medical Research Center, University of Oulu, Oulu, Finland; 5 Biomechanics Labs, Cranfield Forensic Institute, Cranfield University, DA of the UK; ; 6 EpiDoC Unit, CEDOC, NOVA Medical School, NOVA University, Lisbon, Portugal; 7 Rheumatology Department, Centro Hospitalar de Lisboa Norte, EPE, Hospital de Santa Maria, Lisbon Academic Medical Centre, Lisbon, Portugal ABSTRACT Rheumatoid arthritis (RA) causes immune mediated local and systemic bone damage. Objectives - The main goal of this work was to analyze, how treatment intervention with tofacitinib prevents the early disturbances on bone structure and mechanics in adjuvant induced arthritis rat model. This is the first study to access the impact of tofacitinib on the systemic bone effects of inflammation. Methods - Fifty Wistar adjuvant-induced arthritis (AIA) rats were randomly housed in experimental groups, as follows: non-arthritic healthy group (N=20), arthritic non-treated (N=20) and 10 animals under tofacitinib treatment. Rats were monitored during 22 days after disease induction for the inflammatory score, ankle perimeter and body weight. Healthy non-arthritic rats were used as controls for comparison. After 22 days of disease progression rats were sacrificed and bone samples were collected for histology, micro computed tomography (micro-CT), 3-point bending and nanoindentation analysis. -
The Rheumatoid Thumb
THE RHEUMATOID THUMB BY ANDREW L. TERRONO, MD The thumb is frequently involved in patients with rheumatoid arthritis. Thumb postures can be grouped into a number of deformities. Deformity is determined by a complex interaction of the primary joint, the adjacent joints, and tendon function and integrity. Joints adjacent to the primarily affected one usually assume an opposite posture. If they do not, tendon ruptures should be suspected. Surgical treatment is individualized for each patient and each joint, with consideration given to adjacent joints. The treatment consists of synovectomy, capsular reconstruction, tendon reconstruction, joint stabilization, arthrodesis, or arthroplasty. Copyright © 2001 by the American Society for Surgery of the Hand he majority of patients with rheumatoid ar- ring between the various joints. Any alteration of thritis will develop thumb involvement.1,2,3 posture at one level has an effect on the adjacent joint. TThe deformities encountered in the rheuma- The 6 patterns of thumb postures described here, toid patient are varied and are the result of changes unfortunately, do not exhaust the deformities one taking place both intrinsically and extrinsically to the encounters in rheumatoid arthritis (Table 1). It is thumb. Synovial hypertrophy within the individual possible, for example, for the patient to stretch the thumb joints leads not only to destruction of articular supporting structures of a joint, causing a flexion, cartilage, but can also stretch out the supporting extension, or lateral deformity. However, instead of collateral ligaments and joint capsules. As a result, the adjacent joint assuming the opposite posture, it each joint can become unstable and react to the may assume an abnormal position secondary to a stresses applied to it both in function against the other tendon rupture. -
Imaging in Psoriatic Arthritis
Review Standardizing the monitoring of outcome measures: imaging in psoriatic arthritis The wide spectrum of manifestations of musculoskeletal inflammation in psoriatic arthritis makes standardized assessment of joint damage in psoriatic arthritis a challenge. Assessment of erosions and joint space narrowing on plain radiographs of the hands and feet has remained the benchmark for assessing damage in psoriatic arthritis. The methods used to assess damage have been mostly borrowed from those used in rheumatoid arthritis. Axial joint involvement has not been systematically addressed. Methods to assess spinal disease have been borrowed from those used in ankylosing spondylitis. Both ultrasound and MRI have demonstrated promise in the assessment of psoriatic arthritis. The Outcome Measures in Rheumatology Clinical Trials (OMERACT) group is involved in the development of valid, reliable and feasible methods for assessment of joint involvement in psoriatic arthritis. † KEYWORDS: inflammation n joint damage n MRI n psoriasis n radiography Dafna D Gladman n spondylitis n ultrasonography n validation & Vinod Chandran1 1Psoriatic Arthritis Program, University Health Network, 1E 412, 399 Bathurst Psoriatic arthritis (PsA) is an inflammatory and validates outcome measures in rheumato- Street, Toronto, Ontario, M5T 2S8, musculo skeletal disease associated with psoria- logy, identified several measures that should be Canada †Author for correspondence: sis [1]. Psoriasis is an inflammatory, immune- assessed in patients with PsA [6]. These include University -
Pathogenesis of Bone Erosions in Rheumatoid Arthritis: Not Only
Rossini et al. J Rheum Dis Treat 2015, 1:2 ISSN: 2469-5726 Journal of Rheumatic Diseases and Treatment Review Article: Open Access Pathogenesis of Bone Erosions in Rheumatoid Arthritis: Not Only Inflammation Maurizio Rossini*, Angelo Fassio, Luca Idolazzi, Ombretta Viapiana, Elena Fracassi, Giovanni Adami, Maria Rosaria Povino, Maria Vitiello and Davide Gatti Department of Medicine, Rheumatology Unit, University of Verona, Italy *Corresponding author: Maurizio Rossini, Department of Medicine, Rheumatology Unit, Policlinico Borgo Roma, Piazzale Scuro, 10, 37134, Verona, Italy, Tel: +390458126770, Fax: +39O458126881, E-mail: [email protected] patients has evidence of focal bone erosions [3]. This phenomenon Abstract is the result of many complex interactions from the cells and the It is a matter of fact that the inflammatory pathogenesis does not cytokines/chemokines system at the synovial and surrounding explain all the skeletal manifestations of Rheumatoid Arthritis tissues level, which culminates with bone destruction. In addition (RA), and the development of bone involvement is sometimes unconnected from the clinical scores of inflammation. On the to the articular crumbling, RA is also associated with a generalized basis of recent studies, we would like to make a point of the new bone loss with a higher prevalence of osteoporosis: RA patients have available evidence about the metabolic pathogenic component double the normal risk of undergoing a femoral fracture [4] and they of bone erosions. We assume that in this process an additional are 4 times more likely to have vertebral fractures [5,6]. Both erosions role could be played by metabolic factors, such as the parathyroid and systemic osteoporosis are related to the unbalance between hormone (PTH), DKK1 (the inhibitor of the Wnt/β catenin pathway) osteoblasts and osteoclasts activity [7,8]. -
IL-1Β-Driven Osteoclastogenic T Regulatory Cells Accelerate Bone Erosion in Arthritis
IL-1β-driven osteoclastogenic T regulatory cells accelerate bone erosion in arthritis Anaïs Levescot, … , Julia F. Charles, Peter A. Nigrovic J Clin Invest. 2021. https://doi.org/10.1172/JCI141008. Research In-Press Preview Autoimmunity Inflammation Graphical abstract Find the latest version: https://jci.me/141008/pdf Osteoclastogenic Tregs IL-1-driven osteoclastogenic T regulatory cells accelerate bone erosion in arthritis Anaïs Levescot1, Margaret H. Chang1,2, Julia Schnell1,3, Nathan Nelson-Maney1, Jing Yan1,4, Marta Martínez-Bonet1, Ricardo Grieshaber-Bouyer1, Pui Y. Lee1,2, Kevin Wei1, Rachel B. Blaustein1, Allyn Morris1, Alexandra Wactor1, Yoichiro Iwakura5, James A. Lederer6, Deepak A. Rao1, Julia F. Charles1,4, and Peter A. Nigrovic1,2 1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston MA, USA 2Division of Immunology, Boston Children’s Hospital, Boston MA, USA 3Department of Medicine V, Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany 4Department of Orthopaedic Surgery, Brigham and Women’s Hospital, Boston MA, USA 5Center for Experimental Animal Models, Research Institute for Science & Technology, Tokyo University of Science, Tokyo, Japan 6Department of Surgery, Brigham and Women’s Hospital, Boston MA, USA Correspondence: Peter A. Nigrovic, MD Chief, Division of Immunology Boston Children’s Hospital Karp Family Research Building, Room 10211 One Blackfan Circle Boston, MA 02115 Ph: 617-905-1373 Email: [email protected] All authors declare no related conflicts of interest. 1 Osteoclastogenic Tregs Abstract IL-1 is a pro-inflammatory mediator with roles in innate and adaptive immunity. Here we show that IL-1 contributes to autoimmune arthritis by inducing osteoclastogenic capacity in T regulatory cells (Tregs). -
Drug Class Review on Targeted Immune Modulators
Drug Class Review on Targeted Immune Modulators Final Report December 2005 The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports. Gerald Gartlehner, MD, MPH Richard A. Hansen, PhD Patricia Thieda, MA Beth Jonas, MD Kathleen N. Lohr, PhD Tim Carey, MD, MPH Produced by RTI-UNC Evidence-based Practice Center Cecil G. Sheps Center for Health Services Research University of North Carolina at Chapel Hill 725 Airport Road, CB# 7590 Chapel Hill, NC 27599-7590 Tim Carey, MD, MPH, Director Oregon Evidence-based Practice Center Mark Helfand, MD, MPH, Director Copyright © 2005 by Oregon Health & Science University Portland, Oregon 97201. All rights reserved Final Report Drug Effectiveness Review Project TABLE OF CONTENTS List of Abbreviations ............................................................................................................................... 4 Introduction............................................................................................................................................... 6 Scope and Key Questions ............................................................................................................. 12 Methods -
Clinical Presentation of Psoriatic Arthritis Among Sudanese: Hospital Based Study
International Journal of Research Article Clinical Rheumatology Clinical presentation of psoriatic arthritis among sudanese: hospital based study Back ground: Psoriasis is a common papulo-squamous disorder affecting 2% of the population and Nasereldin Hamednalla Elasha is characterized by well demarcated red scaly plaques. Psoriatic Arthritis (PsA) may be defined as Hamednalla1,2,3,4, El nour an inflammatory arthritis which is seronegative for Rheumatoid Factor (RF) and enthesitis that is Mohammed El agib1, 2, Safi associated with psoriasis. The aims of our study is to identify different clinical presentations and Eldin Elnour Ali5, Mohammed types of psoriatic arthritis. Elmujtba Adam Essa*6 Methods: This is a descriptive cross sectional hospital based study conducted at Omdurman military 1Department of Internal Medicine and Rheumatology, Omdurman Military Hospital, hospital, Khartoum, Sudan, for a period of six months. The study included 96 patients confirm Omdurman, Khartoum, Sudan diagnosed by dermatologist as psoriasis, the data obtain with designed questionnaire contains the 2Department of Rheumatology, Sudan clinical presentations of the disease, lab result and radiological imaging, the study analyzed by SPSS Medical Specializations Board, Khartoum, v.20 by using one way a nova method to determine the P. value. Sudan 3Department of internal Medicine, Karary Results: From the total number of patients with Psoriasis, more than one third was psoriatic arthritis, University, Omdurman, Khartoum, Sudan 4Department of Internal Medicine, Ahfad 6% of patients with psoriatic arthritis were oligo-arthritis joint involvements, 14% were polyarthritis, university, Omdurman, Khartoum, Sudan 9% were distal inter phalangeal joint, 9% were spondylitis/sacroillitis and the remaining 5% were 5Department of Dermatology, Omdurman arthritis mutilants. -
Project Plan – November 2016
American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) Psoriatic Arthritis Guideline Project Plan – November 2016 PARTICIPANTS Core Oversight Team Veronica Richardson, NP Jasvinder Singh, MD, MPH (Principal Investigator, Jose Scher, MD Voting Panel Leader) Evan Siegel, MD James Reston, MD (Literature Review Leader) Michael Siegel, PhD Dafna Gladman, MD (Content Expert) Ingrid Steinkoenig Alexis Ogdie, MD, MSCE (Content Expert) Jessica Walsh, MD Gordon Guyatt, MD (GRADE Expert) Patient Panel Literature Review Team Eddie Applegate Helena Jonsson, MD Gail C. Richardson Amit Aakash Shah, MD, MPH Hilary Wilson Nancy Sullivan, BA Marat Turgunbaev, MD, MPH ACR Staff Robin Lane Voting Panel Amy S. Miller Chad Deal, MD Regina Parker Atul Deodhar, MD Deborah Desir, MD NPF Staff Maureen Dubreuil, MD Emily Boyd Jonathan Dunham, MD Elaine Husni, MD, MPH ECRI Institute Staff Sarah Kenny Karen Schoelles, MD Paula Marchetta, MD, MBA Phil Mease, MD Julie Miner, PT Christopher Ritchlin, MD, MPH Ben Smith, PA-C Abby Van Voorhees, MD Expert Panel Laura Coates, MD Marina Magrey, MD Joseph Merola, MD, MMSC Ben Nowell, PhD Ana-Maria Orbai, MD Soumya Reddy, MD 1 American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) Psoriatic Arthritis Guideline Project Plan – November 2016 1 2 ORGANIZATIONAL LEADERSHIP AND SUPPORT 3 4 This collaborative project of the American College of Rheumatology (ACR) and the National Psoriasis 5 Foundation has the broad objective of developing an evidence-based clinical practice guideline for the 6 management of psoriatic arthritis (PsA), not covering skin manifestations of psoriasis. 7 8 BACKGROUND 9 10 Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis. -
Distinguishing Rheumatoid Arthritis from Psoriatic Arthritis
Psoriatic arthritis RMD Open: first published as 10.1136/rmdopen-2018-000656 on 13 August 2018. Downloaded from REVIEW Distinguishing rheumatoid arthritis from psoriatic arthritis Joseph F Merola,1 Luis R Espinoza,2 Roy Fleischmann3 To cite: Merola JF, Espinoza LR, ABSTRACT Key messages Fleischmann R. Distinguishing Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) rheumatoid arthritis from have key differences in clinical presentation, radiographic What is already known about this subject? psoriatic arthritis. RMD Open findings, comorbidities and pathogenesis to distinguish Rheumatoid arthritis (RA) and psoriatic arthritis 2018;4:e000656. doi:10.1136/ between these common forms of chronic inflammatory ► rmdopen-2018-000656 (PsA) are both common chronic inflammatory dis- arthritis. Joint involvement is typically, but not always, eases, and differentiation of these conditions can be asymmetric in PsA, while it is predominantly symmetric in challenging. ► Prepublication history for RA. Bone erosions, without new bone growth, and cervical this paper is available online. spine involvement are distinctive of RA, while axial spine To view these files, please visit What does this study add? involvement, psoriasis and nail dystrophy are distinctive ► We review key differences in clinical, serological, ra- the journal online (http://dx. doi. of PsA. Patients with PsA typically have seronegative test org/ 10. 1136/ rmdopen- 2018- diographic and pathogenic features of RA and PsA, findings for rheumatoid factor (RF) and cyclic citrullinated 000656). and provide practical guidance for achieving a cor- peptide (CCP) antibodies, while approximately 80% of rect diagnosis. Received 31 January 2018 patients with RA have positive findings for RF and CCP Revised 25 May 2018 antibodies.